Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of the Combined Ablation Procedure to Treat Paroxysmal Atrial Fibrillation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years; \< 80 years~* Left atrium less than or equal to 6.5 cm (TTE)~* Symptomatic paroxysmal AF~* Provided written informed consent~* Refractory to at least one AAD (class I, II, III or IV)~Exclusion Criteria:~* Patients requiring concomitant surgery~* Left ventricular ejection fraction \< 30%~* Pregnant or planning to become pregnant during study~* Co-morbid medical conditions that limit one year life expectancy~* Measured left ventricular wall thickness \> 1.5 cm~* History of coagulopathy~* Previous cardiac surgery~* Right ventricular outflow tract obstruction~* History of pericarditis~* Previous cerebrovascular accident (CVA), excluding fully resolved TIA~* Patients who have severe chronic obstructive pulmonary disease (COPD)~* Patients who have an active infection or sepsis~* Patients who have uncorrected reversible cause(s) of AF~* Patients who are contraindicated for anticoagulants~* Patients who are being treated for arrhythmias other than AF~* Patients who have had any previous AF or left atrial catheter ablation~* Current participation in another clinical investigation of a medical device or a drug, or recent participation in such a study within 30 days prior to study enrollment.~* Not competent to legally represent him or herself (e.g., requires a guardian or caretaker as a legal representative).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Numeris-AF Guided Coagulation System (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).